[Federal Register Volume 63, Number 56 (Tuesday, March 24, 1998)]
[Notices]
[Page 14127]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-7553]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Closed Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Cancer Institute Special Emphasis Panel (SEP) meeting:
Name of SEP: Oncogene Deregulation and Tumor Suppressor Gene
Loss of Function in CLL.
Date: April 13-15, 1998.
Time: April 13--7:00 p.m. to Recess, April 14--8:00 a.m. to
Recess, April 15--8:00 a.m. to Adjournment.
Place: The Latham Hotel, 135 South Seventeenth Street,
Philadelphia, Pennsylvania 19103.
Contact Person: Kevin Ryder, Ph.D., Scientific Review
Administrator, National Cancer Institute, NIH, Executive Plaza
North, Room 611D, 6130 Executive Boulevard, MSC 7403, Bethesda, MD
20892-7403, Telephone: 301/402-2785.
Purpose/Agenda: To review, discuss and evaluate grant
applications.
The meeting will be closed in accordance with the provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. Application
and the discussions could reveal confidential trade secrets or
commercial property such as patentable material and personal
information concerning individuals associated with the application,
the disclosure of which would constitute a clearly unwarranted
invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control)
Dated: March 17, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-7553 Filed 3-23-98; 8:45 am]
BILLING CODE 4140-01-M
